Top 5 Funds on Morningstar

Which are the most popular funds according to Morningstar readers? Our top 5 list shows a bias towards home-grown stocks, and healthcare funds

Karen Kwok 25 February, 2016 | 10:46AM

Amid a background of market volatility investors appear to be playing it safe. Equity income and Absolute Return funds feature prominently in the December list of the five most popular funds on Morningstar.co.uk. However, some more gung-ho investors were still keen on higher risk biotech funds.

Still top of the pops with Morningstar readers is Bronze-Rated fund CF Woodford Equity Income.  The fund has been at top of this list since June last year.

 Morningstar analyst Daniel Vaughan says the fund manager, Neil  Woodford, has delivered outstanding long-term returns. He has proved willing to stick to his strategy even during periods of poor performance and as a result has a long-term track record that encompasses numerous market cycles.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
Rating
AstraZeneca PLC7,144.00 GBP0.00
AXA Framlington Biotech GBP Z Acc369.19 GBP3.36
Gilead Sciences Inc78.21 USD0.00
GlaxoSmithKline PLC1,489.40 GBP0.00
Imperial Brands PLC1,563.50 GBP0.00
Invesco High Income UK Acc507.23 GBP-2.31
LF Woodford Equity Income A Sterling Acc14.81 GBP-0.27
Schroder ISF Glb Div Mxmsr A Dis QF2.96 USD0.32
SLI Global Absolute Ret Strat Ret Acc74.72 GBP0.28

About Author

Karen Kwok

Karen Kwok  is a Reporter for Morningstar.co.uk

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites